And it has been preclinically showed that deficiency of TSC2 or PTEN expression induces impaired PI3K/Akt/mTOR activation, suggesting that mTOR overexpression with the loss of PTEN plays a key role in the development and progression of pancreatic neuroendocrine tumors [33]. This evidence concerns the gene PTEN and pancreatic neuroendocrine tumor.